USAA MSCI USA Value Mom Blnd ETF

Most Recent

  • uploads///feit
    Company & Industry Overviews

    Why Galmed Pharmaceuticals Stock Rose 151% on June 12

    Galmed Pharmaceuticals stock rose 151.3% on June 12. The stock closed at $17.59, which is a 387% increase from its 52-week low of $3.61 on February 14.

    By Daniel Collins
  • uploads///Part_graph
    Miscellaneous

    Robust Urology Pipeline Could Drive UroGen Pharma’s Stock Price

    The 12-month consensus analyst recommendation for UroGen Pharma on September 25 is a “strong buy.”

    By Margaret Patrick
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.